Klingman & Associates’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-200
Closed -$7K 123
2016
Q3
$7K Hold
200
﹤0.01% 308
2016
Q2
$7K Hold
200
﹤0.01% 311
2016
Q1
$7K Hold
200
﹤0.01% 313
2015
Q4
$8K Buy
+200
New +$8.15K ﹤0.01% 313
2015
Q3
Sell
-200
Closed -$8.84K 335
2015
Q2
$9K Hold
200
﹤0.01% 312
2015
Q1
$9K Hold
200
﹤0.01% 284
2014
Q4
$8K Buy
+200
New +$8.22K ﹤0.01% 296

Other funds holding BME

Klingman & Associates's BME Position: Q4 2016 in Review

Klingman & Associates sold out of BlackRock Health Sciences Trust (BME) in Q4 2016, closing a stake of 200 shares — an estimated $7K sold.

Klingman & Associates first reported a position in BME in Q4 2014 and held it in 7 quarters. The position peaked at $9K in Q2 2015. 34 funds tracked by Wall St. Rank hold BME as of Q4 2016.

  • Klingman & Associates reported no remaining BlackRock Health Sciences Trust position as of Q4 2016 after selling out during the quarter.
  • Klingman & Associates sold 200 BlackRock Health Sciences Trust shares in Q4 2016, an estimated $7K.
  • Klingman & Associates first reported a position in BlackRock Health Sciences Trust in Q4 2014 and held it in 7 quarters.
  • Klingman & Associates's BlackRock Health Sciences Trust position peaked at $9K in Q2 2015.
  • 34 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2016.

Based on Klingman & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.